PapersFlow Research Brief
Sepsis Diagnosis and Treatment
Research Guide
What is Sepsis Diagnosis and Treatment?
Sepsis diagnosis and treatment encompasses the clinical identification of sepsis and septic shock using consensus definitions and scoring systems, along with management strategies including early goal-directed therapy, antimicrobial administration, and supportive care to improve patient outcomes in critical care settings.
The field includes 93,149 works on the epidemiology, diagnosis, management, and prognosis of sepsis and septic shock. Key approaches involve clinical criteria from "The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)" (Singer et al., 2016) and organ failure assessment via the SOFA score (Vincent et al., 1996). Prediction models like APACHE II (Knaus et al., 1985) measure disease severity using physiologic data, age, and health status.
Topic Hierarchy
Research Sub-Topics
Sepsis-3 Definition
Sepsis-3 research develops and validates the 2016 consensus criteria using SOFA scores for organ dysfunction and qSOFA for rapid identification. Studies compare its performance against prior definitions in diverse ICU populations.
Sepsis Biomarkers
Sepsis biomarkers evaluate novel blood-based indicators like procalcitonin, presepsin, and cell-free DNA for early diagnosis and severity stratification. Meta-analyses and prospective cohorts assess diagnostic accuracy and prognostic value.
SOFA Score
SOFA score studies refine the Sequential Organ Failure Assessment tool for dynamic organ dysfunction monitoring in septic patients. Research optimizes scoring for prediction of ICU outcomes and resource allocation.
Surviving Sepsis Campaign Guidelines
This sub-topic analyzes implementation, adherence, and outcomes of Surviving Sepsis Campaign bundles including fluid resuscitation and antibiotics. Cluster trials evaluate guideline impact on hospital mortality.
Early Goal-Directed Therapy
Early goal-directed therapy research tests protocolized hemodynamic optimization in sepsis resuscitation using protocols like Rivers' EGDT. Recent trials assess protocol modifications amid controversies from ProCESS, ARISE, and ProMISe studies.
Why It Matters
Sepsis diagnosis and treatment directly impacts survival in critical care, where early recognition via Sepsis-3 criteria enables timely intervention (Singer et al., 2016). "Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock" (Rivers et al., 2001) demonstrated significant outcome benefits, reducing mortality in severe cases. The "Surviving Sepsis Campaign" (Dellinger et al., 2013) provides guidelines from 68 experts across 30 organizations, standardizing antimicrobial therapy and fluid resuscitation. Intensive insulin therapy maintaining glucose below 110 mg/dL reduced morbidity and mortality in surgical ICU patients (Van den Berghe et al., 2001). These protocols address high mortality risks, as seen in COVID-19 cohorts with detailed risk factors (Zhou et al., 2020).
Reading Guide
Where to Start
"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)" (Singer et al., 2016) provides the foundational clinical criteria and replaces prior definitions, making it the essential starting point for understanding modern sepsis diagnosis.
Key Papers Explained
"Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis" (Bone et al., 1992) established early consensus on sepsis and organ failure. Singer et al. (2016) updated these in Sepsis-3 with SOFA-based criteria for greater trial consistency. Vincent et al. (1996) detailed the SOFA score central to Sepsis-3. Rivers et al. (2001) introduced early goal-directed therapy as a treatment cornerstone. Dellinger et al. (2013) synthesized these into Surviving Sepsis Campaign guidelines. Knaus et al. (1985) APACHE II complements with severity scoring.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current frontiers emphasize prognostic models integrating biomarkers with SOFA and APACHE II, as implied in the cluster's focus on prediction models. Sepsis-3 (Singer et al., 2016) calls for validation in diverse settings. No recent preprints available, but management evolves via Surviving Sepsis updates building on Dellinger et al. (2013).
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Clinical course and risk factors for mortality of adult inpati... | 2020 | The Lancet | 28.8K | ✓ |
| 2 | The Third International Consensus Definitions for Sepsis and S... | 2016 | JAMA | 26.0K | ✓ |
| 3 | APACHE II | 1985 | Critical Care Medicine | 13.3K | ✕ |
| 4 | Definitions for Sepsis and Organ Failure and Guidelines for th... | 1992 | CHEST Journal | 13.1K | ✓ |
| 5 | The SOFA (Sepsis-related Organ Failure Assessment) score to de... | 1996 | Intensive Care Medicine | 11.2K | ✕ |
| 6 | Heat Shock Protein A12B Protects Vascular Endothelial Cells Ag... | 2017 | Cellular Physiology an... | 10.7K | ✓ |
| 7 | Early Goal-Directed Therapy in the Treatment of Severe Sepsis ... | 2001 | New England Journal of... | 10.7K | ✓ |
| 8 | Intensive Insulin Therapy in Critically Ill Patients | 2001 | New England Journal of... | 10.0K | ✓ |
| 9 | Surviving Sepsis Campaign | 2013 | Critical Care Medicine | 9.7K | ✕ |
| 10 | Acute Respiratory Distress Syndrome | 2012 | JAMA | 8.7K | ✕ |
Frequently Asked Questions
What are the Sepsis-3 definitions for sepsis and septic shock?
Sepsis-3 defines sepsis as life-threatening organ dysfunction caused by a dysregulated host response to infection, identified by an increase of 2 or more points in the SOFA score. Septic shock is a subset with circulatory and cellular/metabolic abnormalities, marked by vasopressor needs to maintain mean arterial pressure of 65 mm Hg and lactate >2 mmol/L despite fluid resuscitation. These criteria replace prior definitions for better consistency in studies and trials (Singer et al., 2016).
How does the APACHE II score function in sepsis?
APACHE II assigns a point score from 12 routine physiologic measurements, age, and prior health status to quantify disease severity. Higher scores indicate greater risk of hospital mortality. It serves as a general measure for critically ill patients, including those with sepsis (Knaus et al., 1985).
What is the role of the SOFA score in sepsis diagnosis?
The SOFA score assesses organ dysfunction or failure in sepsis across six systems: respiratory, cardiovascular, hepatic, coagulation, renal, and neurological. It provides a simple method to describe and quantify severity daily in ICU patients. Changes in SOFA scores track progression or response to therapy (Vincent et al., 1996).
What does early goal-directed therapy involve for septic shock?
Early goal-directed therapy targets central venous oxygen saturation >70%, central venous pressure 8-12 mm Hg, and mean arterial pressure >65 mm Hg in severe sepsis and septic shock. It improves outcomes through protocolized resuscitation within 6 hours. This approach showed significant survival benefits in clinical trials (Rivers et al., 2001).
What guidelines does the Surviving Sepsis Campaign provide?
The Surviving Sepsis Campaign updates management guidelines for severe sepsis and septic shock, emphasizing early antibiotics, fluids, and vasopressors. Developed by 68 experts from 30 organizations using nominal group techniques. It builds on prior 2008 recommendations for evidence-based care (Dellinger et al., 2013).
How does intensive insulin therapy benefit septic patients?
Intensive insulin therapy targets blood glucose at or below 110 mg per deciliter in critically ill patients. It reduces morbidity and mortality, particularly in surgical ICUs. Benefits extend to sepsis management by mitigating hyperglycemia-related complications (Van den Berghe et al., 2001).
Open Research Questions
- ? How can biomarkers improve early sepsis detection beyond clinical scores like SOFA and APACHE II?
- ? What refinements to early goal-directed therapy protocols address limitations seen in post-Rivers et al. (2001) trials?
- ? In what ways do host genetic factors influence sepsis prognosis and response to antimicrobial therapy?
- ? How do microcirculation changes during septic shock affect organ failure assessment?
- ? What updates to Sepsis-3 definitions account for sepsis in non-ICU or viral infection contexts like COVID-19?
Recent Trends
The field encompasses 93,149 works with sustained focus on epidemiology and prognostic models.
High citation of Zhou et al. reflects integration of COVID-19 data into sepsis risk assessment.
2020No growth rate data or recent preprints/news available.
Research Sepsis Diagnosis and Treatment with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Sepsis Diagnosis and Treatment with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers